COAST GUARD VETERAN WALKING ACROSS AMERICA TO RAISE AWARENESS FOR MENTAL HEALTH
The Coast Guard Foundation, a non-profit organization committed to strengthening the Coast Guard community and service by supporting members and…
Author: Åse Knutsen
Ohh-Med Medical Launches VerticaPlus Device with a Mobile App Featuring Real-time Feedback & Guided Support
Ohh-Med Medical, a leader in the fast-growing market of interventional urology and men’s health, is launching the next-generation VerticaPlus with…
Introducing Ignians’ Total Multivitamin & Sleep Aid Capsules: The Ultimate Solution for High Performers
As the demands of modern life continue to increase, high performers in various industries understand the crucial connection between health…
PharmaLogic announces opening of radiopharmaceutical production facility in New York City
PharmaLogic Holdings Corp., (“PharmaLogic” or “the company”), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, celebrates…
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive…
CMUH (Taiwan) Launches “Intelligent Sepsis Early Prediction System (ISEPS),” Detecting Sepsis in One Minute Only
In conventional practice, a blood culture report wouldn’t be available until 18 to 72 hours later, rendering it non-feasible to…
Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the…
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure
CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron deficiency anemia…
Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA
Arctic Therapeutics ehf, an Icelandic drug development company and partner Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for…
Ultimovacs announces publication of results from NIPU Phase II trial with UV1 vaccination in mesothelioma in European Journal of Cancer
Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the results from the…